Clinical Study on Second-eye Pain in Cataract Surgery

NCT ID: NCT03766230

Last Updated: 2018-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-12-30

Study Completion Date

2021-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The degree of perceived pain in the second-eye surgery of cataract patients is significantly higher than that in the first-eye surgery, which can lead to nervous tension during surgery and affect the surgical outcome and satisfaction. Study suggested that in addition to psychological factors, there might be subclinical sympathetic reactions leading to increased pain in the second-eyes, but the objective indicators and clinical relevance are not clear. Therefore, it is necessary to study the mechanism of second-eye pain in cataract surgery, and to provide a test index that can effectively predict the degree of intraoperative pain in patients, as an important reference for the development of a suitable time for second eye surgery.

This study is based on clinical case studies, recruiting patients with clinically diagnosed binocular age-related cataract and require binocular surgery, to compare the correlation of intraocular inflammatory factors in the second eye and patients' self-pain scores while both eyes' surgery are completed by the same doctor in the same operating room, and the correlation of the change of inflammatory factors and the time interval between the two eyes surgery, to analyze the second-eye subclinical sympathetic reaction changing with the time interval after the first cataract surgery from the molecular biological results. Using the latest international anterior segment vascularization optical coherence tomography(OCT) scan and optical microvascular imaging(OMAG) analysis technology to quantify iris blood flow, this study analyzes the iris blood flow density, vascular density and other indicators before and after cataract surgery, and carry out its correlation with the degree of intraocular subclinical sympathetic reaction, providing a rapid, non-invasive objective examination index of the second-eye subclinical sympathetic response.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Coordination and Quality Control Team: The inspection and audit of this research project will be established mainly by hospital clinical research center staff and assisted by the Ophthalmology Reading Center team;
2. The project team member will accept training before the study begins while unified inspection methods and requirements is established in standard operating procedures.
3. The project team double enter the test data independently and establishes an electronic database.
4. The project team randomly selects the data and repeats the measurements to ensure the accuracy as internal audit regularly.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Senile Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

peribulbar anesthesia1

Time interval between two eyes' cataract surgery is or less than 14 days and using peribulbar anesthesia

No interventions assigned to this group

topical anesthesia1

Time interval between two eyes' cataract surgery is or less than 14 days and using topical anesthesia

No interventions assigned to this group

peribulbar anesthesia2

Time interval between two eyes' cataract surgery is from 15 to 21 days and using peribulbar anesthesia

No interventions assigned to this group

topical anesthesia2

Time interval between two eyes' cataract surgery is from 15 to 21 days and using topical anesthesia

No interventions assigned to this group

peribulbar anesthesia3

Time interval between two eyes' cataract surgery is from 22 to 28 days and using peribulbar anesthesia

No interventions assigned to this group

topical anesthesia3

Time interval between two eyes' cataract surgery is from 22 to 28 days and using topical anesthesia

No interventions assigned to this group

peribulbar anesthesia4

Time interval between two eyes' cataract surgery is from 29 to 60 days and using peribulbar anesthesia

No interventions assigned to this group

topical anesthesia4

Time interval between two eyes' cataract surgery is from 29 to 60 days and using topical anesthesia

No interventions assigned to this group

peribulbar anesthesia5

Time interval between two eyes' cataract surgery is from 61 to 90 days and using peribulbar anesthesia

No interventions assigned to this group

topical anesthesia5

Time interval between two eyes' cataract surgery is from 61 to 90 days and using topical anesthesia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. diagnosed with binocular age-related cataract.
2. Both eyes require phacoemulsification and intraocular lens implantation.
3. binocular surgery was performed by the same physician in the same operating room, and the anesthesia and surgical procedures were consistent.
4. Patients can fully understand the research purpose, research content, accidents and benefits and risks of the clinical trial, and can make their own decisions on participating or not.

Exclusion Criteria

\-
Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

Sponsor Role collaborator

Shanghai Eye Disease Prevention and Treatment Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

YFZX2018006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.